UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.429

Sortiert nach

Digitizing clinical trials

NPJ digital medicine, 2020-07, Vol.3 (1), p.101-101, Article 101

2020

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF

Journal of clinical pharmacology, 2014-08, Vol.54 (8), p.917-927

2014

Volltextzugriff (PDF)

Impediments to Clinical Research in the United States

Clinical pharmacology and therapeutics, 2012-03, Vol.91 (3), p.535-541

2012

Volltextzugriff (PDF)

Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation

Circulation (New York, N.Y.), 2002-05, Vol.105 (19), p.2253-2258

2002

Volltextzugriff (PDF)

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

Diabetic medicine, 2015-08, Vol.32 (8), p.1090-1096

2015

Volltextzugriff (PDF)

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction : Results of a multicenter, randomized, placebo-controlled trial : The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

Journal of the American College of Cardiology, 1999-11, Vol.34 (6), p.1711-1720

1999

Volltextzugriff (PDF)

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

The American heart journal, 1997-07, Vol.134 (1), p.44-54

1997

Volltextzugriff (PDF)

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

The American heart journal, 1999-07, Vol.138 (1), p.78-86

1999

Volltextzugriff (PDF)

Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis

Clinical pharmacology and therapeutics, 2008-09, Vol.84 (3), p.315-319

2008

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Circulation (New York, N.Y.), 1999-11, Vol.100 (20), p.2045-2048

1999

Volltextzugriff (PDF)

Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials

Clinical pharmacology and therapeutics, 2010-06, Vol.87 (6), p.668-671

2010

Volltextzugriff (PDF)

Prognostic value of the admission electrocardiogram in acute coronary syndromes

JAMA : the journal of the American Medical Association, 1999-02, Vol.281 (8), p.707

1999

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Journal of the American College of Cardiology, 2000-04, Vol.35 (5), p.1103-1115

2000

Volltextzugriff (PDF)

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Circulation (New York, N.Y.), 1998-12, Vol.98 (25), p.2829-2835

1998

Volltextzugriff (PDF)

Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction

The New England journal of medicine, 1995-05, Vol.332 (21), p.1418-1424

1995

Volltextzugriff (PDF)

Integrated Efficacy to Effectiveness Trials

Clinical pharmacology and therapeutics, 2014-02, Vol.95 (2), p.131-133

Califf, R M

2014

Volltextzugriff (PDF)

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

The New England journal of medicine, 1997-08, Vol.337 (7), p.447-452

1997

Volltextzugriff (PDF)

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

The New England journal of medicine, 1997-02, Vol.336 (7), p.480-486

1997

Volltextzugriff (PDF)

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

European heart journal, 2004-02, Vol.25 (4), p.313-321

2004

Volltextzugriff (PDF)

Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food & Drug Administration

Clinical and translational science, 2017-05, Vol.10 (3), p.124-127

2017

Volltextzugriff (PDF)

Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting Physician

The New England journal of medicine, 1996-12, Vol.335 (25), p.1880-1887

1996

Volltextzugriff (PDF)

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

The New England journal of medicine, 1996-10, Vol.335 (18), p.1333-1342

1996

Volltextzugriff (PDF)

Cardiogenic shock complicating acute coronary syndromes

The Lancet (British edition), 2000-08, Vol.356 (9231), p.749-756

2000

Volltextzugriff (PDF)

Gender differences in Survival in advanced heart failure : Insights from the FIRST study

Circulation (New York, N.Y.), 1999-04, Vol.99 (14), p.1816-1821

1999

Volltextzugriff (PDF)

Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic Cardiomyopathy

Journal of the American College of Cardiology, 1997-10, Vol.30 (4), p.1002-1008

1997

Volltextzugriff (PDF)

1 – 25 von 1.429

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.397)
Mit Volltextzugriff
(1.316)

Publikationsform

Sprache

Englisch
(1.428)
Japanisch
(176)
Russisch
(2)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(996)
Science & Technology
(973)
Life Sciences & Biomedicine
(957)
Cardiovascular System & Cardiology
(725)
Biological And Medical Sciences
(716)
Medical Sciences
(716)
Cardiac & Cardiovascular Systems
(714)
Female
(622)
Male
(619)
Middle Aged
(571)
Aged
(478)
Cardiology. Vascular System
(353)
Heart
(314)
Treatment Outcome
(278)
Pharmacology. Drug Treatments
(270)
Coronary Heart Disease
(262)
Myocardial Infarction - Drug Therapy
(241)
Risk Factors
(197)
Myocardial Infarction - Mortality
(191)
Peripheral Vascular Disease
(189)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Digitizing clinical trials

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF

Impediments to Clinical Research in the United States

Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation

Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction : Results of a multicenter, randomized, placebo-controlled trial : The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials

Prognostic value of the admission electrocardiogram in acute coronary syndromes

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial Infarction

Integrated Efficacy to Effectiveness Trials

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

Racial Variation in the Use of Coronary-Revascularization Procedures — Are the Differences Real? Do They Matter?

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

Case Study for Lean Management in the Public Sector: Improving Combination Product Review at the Food & Drug Administration

Outcome of Acute Myocardial Infarction According to the Specialty of the Admitting Physician

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

Cardiogenic shock complicating acute coronary syndromes

Gender differences in Survival in advanced heart failure : Insights from the FIRST study

Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic Cardiomyopathy

Suchergebnisse filtern